Lizzul Paul F. — SEC Form 4 filings
SEC reporting owner CIK 1711462. 16 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-01-09 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 9 filings — 21,378 shares, $854,159 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 45.
- Largest priced transaction: sale of 4,219 shares @ $43.26 ($182,514) in ANAPTYSBIO, INC, filed 2026-01-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ANAPTYSBIO, INC (ANAB) | Chief Medical Officer | 12 | — | 9 legs · 21,378 sh · $854,159 | 30 |
| First Tracks Biotherapeutics, Inc. (TRAX) | Chief Medical Officer | 4 | — | — | 15 |
Form 4 filings — Lizzul Paul F.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/award (A): 60,492 (derivative) @ $0 | EDGAR |
| 2026-08-07 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 16,667 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/award (A): 60,492 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 72,300 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/award (A): 83,500 (derivative) @ $0 · Grant/award (A): 45,000 (derivative) @ $0 · Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 67,070 (derivative) @ $0 · Grant/award (A): 115,540 (derivative) @ $0 · Grant/award (A): 97,200 (derivative) @ $0 · +5 more | EDGAR |
| 2026-01-09 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 8,525 · Sale (S): 3,650 @ $44.71 · Option exercise (M): 8,525 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 6,145 · Sale (S): 2,235 @ $45.11 · Option exercise (M): 6,145 (derivative) @ $0 · Grant/award (A): 21,400 (derivative) @ $0 · Grant/award (A): 29,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 10,555 · Sale (S): 4,219 @ $43.26 · Option exercise (M): 10,555 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 1,500 @ $18.50 · Sale (S): 1,500 @ $50 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 10,555 · Tax withholding (F): 4,336 @ $14.60 · Option exercise (M): 6,145 · Tax withholding (F): 2,261 @ $15.30 · Option exercise (M): 10,555 (derivative) @ $0 · Option exercise (M): 6,145 (derivative) @ $0 · +2 more | EDGAR |
| 2024-09-24 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 1,500 @ $18.50 · Sale (S): 1,500 @ $38.67 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2024-09-17 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 6,000 · Sale (S): 2,220 @ $38.93 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2024-08-16 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 2,000 @ $18.50 · Sale (S): 2,000 @ $40 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2024-07-24 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-07-19 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 1,500 @ $18.50 · Sale (S): 1,500 @ $35 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 6,145 @ $0 · Sale (S): 2,554 @ $21.81 · Option exercise (M): 6,145 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1711462 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →